{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:58:24Z","timestamp":1774263504087,"version":"3.50.1"},"reference-count":139,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health of the Russian Federation government","award":["125020401358-1"],"award-info":[{"award-number":["125020401358-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus are dangerous respiratory pathogens with high pandemic potential. Since 2021, these two viruses have been co-circulating, which implies additional risks of co-infection with both pathogens. Prophylactic vaccination is widely recognized as the most effective way to prevent COVID-19 and influenza and to reduce the severity of these diseases. This review analyzes recent data on the simultaneous circulation of influenza and SARS-CoV-2 viruses worldwide, including epidemiological data and the pathogenetic mechanisms of co-infection. Next, we focus on current approaches to simultaneous and combined vaccination against influenza and COVID-19. We outline the types of vaccines and summarize the available findings on the effectiveness and safety of co-vaccination. Methods: A comprehensive search was conducted using PubMed, Scopus, Web of Science, and ClinicalTrials to identify data relevant to SARS-CoV-2 and influenza co-circulation and dual vaccination. Results: Influenza and SARS-CoV-2 cause similar symptoms, and co-infection can significantly enhance the risks of pneumonia and acute respiratory distress syndrome progressing with a poor outcome, especially among children and the elderly. A range of influenza and COVID-19 vaccines built on different technological platforms is currently available on the market, with proven effectiveness, immunogenicity, and safety. A co-vaccination approach is more convenient for patients and is associated with better response to treatment, while also improving vaccine coverage and compliance and offering significant resource savings for healthcare systems. Conclusions: The concurrent circulation of SARS-CoV-2 and influenza viruses presents a growing public health challenge. Simultaneous and combination vaccination strategies have emerged as effective tools to streamline immunization, enhance protection, and reduce healthcare burden. Future studies should elucidate the mechanisms of the exacerbation of respiratory disease caused by co-infection, as well as the optimal strategies for co-administering influenza and COVID-19 vaccines for long-term control of seasonal and potentially pandemic respiratory viruses.<\/jats:p>","DOI":"10.3390\/vaccines14030283","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T09:48:42Z","timestamp":1774259322000},"page":"283","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 and Influenza Co-Circulation and Co-Vaccination: A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-8380","authenticated-orcid":false,"given":"Mohammad","family":"Kamransarkandi","sequence":"first","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5573-1570","authenticated-orcid":false,"given":"Elena A.","family":"Varyushina","sequence":"additional","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey N.","family":"Gorshkov","sequence":"additional","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina A.","family":"Stukova","sequence":"additional","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/00333549101250S305","article-title":"Influenza: The Once and Future Pandemic","volume":"125","author":"Taubenberger","year":"2010","journal-title":"Public Health Rep."},{"key":"ref_2","unstructured":"(2026, March 02). Influenza (Seasonal). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41586-024-08054-z","article-title":"The Global H5N1 Influenza Panzootic in Mammals","volume":"637","author":"Peacock","year":"2025","journal-title":"Nature"},{"key":"ref_4","unstructured":"(2025, December 07). WHO Coronavirus (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_5","unstructured":"(2025, December 07). The Current Epidemic Situation in Russia and the World. Available online: https:\/\/www.rospotrebnadzor.ru\/region\/korono_virus\/epid.php."},{"key":"ref_6","unstructured":"(2025, December 12). World Health Organization Statement on the Fifteenth Meeting of the IHR (2005) Emergency Committee on the COVID-19 Pandemic. Available online: https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ajic.2022.05.009","article-title":"Viral Transmissibility of SARS-CoV-2 Accelerates in the Winter, Similarly to Influenza Epidemics","volume":"50","author":"Inaida","year":"2022","journal-title":"Am. J. Infect. Control"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/cid\/ciab691","article-title":"Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients with Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing","volume":"74","author":"Coleman","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chow, V.T., Tay, D.J.W., Chen, M.I., Tang, J.W., Milton, D.K., and Tham, K.W. (2023). Influenza A and B Viruses in Fine Aerosols of Exhaled Breath Samples from Patients in Tropical Singapore. Viruses, 15.","DOI":"10.3390\/v15102033"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2000058","DOI":"10.2807\/1560-7917.ES.2020.25.4.2000058","article-title":"Pattern of Early Human-to-Human Transmission of Wuhan 2019 Novel Coronavirus (2019-nCoV), December 2019 to January 2020","volume":"25","author":"Riou","year":"2020","journal-title":"Eurosurveillance"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jmv.25674","article-title":"Recent Advances in the Detection of Respiratory Virus Infection in Humans","volume":"92","author":"Zhang","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"104554","DOI":"10.1016\/j.micpath.2020.104554","article-title":"Immunopathological Similarities between COVID-19 and Influenza: Investigating the Consequences of Co-Infection","volume":"152","author":"Khorramdelazad","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Golpour, M., Jalali, H., Alizadeh-Navaei, R., Talarposhti, M.R., Mousavi, T., and Ghara, A.A.N. (2025). Co-Infection of SARS-CoV-2 and Influenza A\/B among Patients with COVID-19: A Systematic Review and Meta-Analysis. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10521-5"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12985-021-01594-0","article-title":"Influenza Co-Infection Associated with Severity and Mortality in COVID-19 Patients","volume":"18","author":"Alosaimi","year":"2021","journal-title":"Virol. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/jmv.26163","article-title":"The Epidemiology and Clinical Characteristics of Co-infection of SARS-CoV-2 and Influenza Viruses in Patients during COVID-19 Outbreak","volume":"92","author":"Yue","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2211685","DOI":"10.1080\/22221751.2023.2211685","article-title":"Reciprocal Enhancement of SARS-CoV-2 and Influenza Virus Replication in Human Pluripotent Stem Cell-Derived Lung Organoids","volume":"12","author":"Kim","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijid.2020.05.068","article-title":"Clinical Characteristics of Critically Ill Patients Co-Infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China","volume":"96","author":"Ma","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_18","unstructured":"World Health Organization (2026, March 10). Coadministration of Seasonal Inactivated Influenza and COVID-19 Vaccines: Interim Guidance Content. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccines-SAGE_recommendation-coadministration-influenza-vaccines?ysclid=mmrkrl2spr920550049."},{"key":"ref_19","unstructured":"Russian Ministry of Health (2025, December 12). The Russian Ministry of Health has Authorized Simultaneous Vaccination Against COVID-19 and Influenza, Available online: https:\/\/minzdrav.gov.ru\/news\/2021\/10\/22\/17665-minzdrav-rossii-razreshil-odnovremennuyu-vaktsinatsiyu-ot-kovida-i-grippa."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.vaccine.2022.12.043","article-title":"Association of Dual COVID-19 and Seasonal Influenza Vaccination with COVID-19 Infection and Disease Severity","volume":"41","author":"Xie","year":"2023","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Akande, O.W., Carter, L.L., Abubakar, A., Achilla, R., Barakat, A., Gumede, N., Guseinova, A., Inbanathan, F.Y., Kato, M., and Koua, E. (2023). Strengthening pathogen genomic surveillance for health emergencies: Insights from the World Health Organization\u2019s regional initiatives. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1146730"},{"key":"ref_22","unstructured":"(2026, March 06). Global Influenza Surveillance and Response System (GISRS). Available online: http:\/\/www.who.int\/initiatives\/global-influenza-surveillance-and-response-system."},{"key":"ref_23","unstructured":"(2026, March 06). Official hCoV-19 Reference Sequence (WIV04). Available online: http:\/\/gisaid.org\/wiv04\/."},{"key":"ref_24","unstructured":"(2026, March 06). SARS-CoV-2 Circulation, World. Available online: http:\/\/data.who.int\/dashboards\/covid19\/circulation."},{"key":"ref_25","unstructured":"World Health Organization (2025, December 12). Influenza and SARS-CoV-2 Virus Detections Reported to FluNet from Countries, Areas and Territories. Available online: https:\/\/app.powerbi.com\/view?r=eyJrIjoiNzc4YTIxZjQtM2E1My00YjYxLWIxMDItNzEzMjkyY2E1MzU1IiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.36233\/0372-9311-556","article-title":"Analysis of Influenza Epidemics during the COVID-19 Pandemic Using an Improved Surveillance System (from 2021 to 2024)","volume":"101","author":"Karpova","year":"2024","journal-title":"J. Microbiol. Epidemiol. Immunobiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e19693","DOI":"10.7717\/peerj.19693","article-title":"Analytical performance evaluation of a multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, influenza A\/B, and RSV","volume":"13","author":"Tai","year":"2025","journal-title":"PeerJ."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bulgurcu, A., and Say\u0131ner, A.A. (2026). Validation of a multiplex qRT-PCR assay for the detection of RSV, influenza A\/B virus and SARS-CoV-2. BMC Microbiol., 26.","DOI":"10.1186\/s12866-025-04646-5"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"30503","DOI":"10.1038\/s41598-025-16434-2","article-title":"Development and clinical validation of a novel multiplex PCR test for detection of respiratory pathogens via fluorescence melting curve analysis","volume":"15","author":"Jiang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Contes, K.M., and Liu, B.M. (2025). Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era. Pathogens, 14.","DOI":"10.3390\/pathogens14030262"},{"key":"ref_31","unstructured":"(2025, March 18). FluCov Dashboard Understanding the Impact of SARS-CoV-2 on Influenza. Available online: https:\/\/www.nivel.nl\/en\/nieuws\/new-flucov-dashboard-offers-clear-view-circulation-2019-influenza-and-covid-19-worldwide."},{"key":"ref_32","unstructured":"World Health Organization (2025, December 07). Global Influenza Programme. Available online: https:\/\/www.who.int\/tools\/flunet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e13090","DOI":"10.1111\/irv.13090","article-title":"Are Twindemics Occurring?","volume":"17","author":"Takashita","year":"2023","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2365","DOI":"10.1002\/rmv.2365","article-title":"Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis","volume":"33","author":"Krumbein","year":"2023","journal-title":"Rev. Med. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Maltezou, H.C., Papanikolopoulou, A., Vassiliu, S., Theodoridou, K., Nikolopoulou, G., and Sipsas, N.V. (2023). COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature. Viruses, 15.","DOI":"10.3390\/v15040865"},{"key":"ref_36","first-page":"100306","article-title":"Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges","volume":"3","author":"Yang","year":"2022","journal-title":"Innovation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100036","DOI":"10.1016\/j.jcvp.2021.100036","article-title":"Co-infection of SARS-CoV-2 and influenza viruses: A systematic review and meta-analysis","volume":"1","author":"Dao","year":"2021","journal-title":"J. Clin. Virol. Plus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"m3720","DOI":"10.1136\/bmj.m3720","article-title":"COVID-19: Risk of Death More than Doubled in People Who Also Had Flu, English Data Show","volume":"370","author":"Iacobucci","year":"2020","journal-title":"BMJ"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s44307-025-00057-9","article-title":"Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: Decipher the ominous tales of immune vulnerability","volume":"3","author":"Mai","year":"2025","journal-title":"Adv. Biotechnol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/iid3.404","article-title":"Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19","volume":"9","author":"Costagliola","year":"2021","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Opatowski, L., Baguelin, M., and Eggo, R.M. (2018). Influenza Interaction with Cocirculating Pathogens and Its Impact on Surveillance, Pathogenesis, and Epidemic Profile: A Key Role for Mathematical Modelling. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006770"},{"key":"ref_42","first-page":"91","article-title":"In Vitro Growth Profiles of Respiratory Syncytial Virus in the Presence of Influenza Virus","volume":"44","author":"Shinjoh","year":"2000","journal-title":"Acta Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3201\/eid2802.211727","article-title":"Viral Interference between Respiratory Viruses","volume":"28","author":"Piret","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Pinky, L., and Dobrovolny, H.M. (2016). Coinfections of the Respiratory Tract: Viral Competition for Resources. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155589"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/infdis\/jiac357","article-title":"Interactions between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human Nasal Epithelium","volume":"226","author":"Pizzorno","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1002\/jmv.26098","article-title":"SARS-CoV-2 Coinfections: Could Influenza and the Common Cold Be Beneficial?","volume":"92","author":"Pinky","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41422-021-00473-1","article-title":"Coinfection with Influenza A Virus Enhances SARS-CoV-2 Infectivity","volume":"31","author":"Bai","year":"2021","journal-title":"Cell Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"106017","DOI":"10.1016\/j.micpath.2023.106017","article-title":"Decreased Expression of Surfactant Protein-C and CD74 in Alveolar Epithelial Cells during Influenza Virus A(H1N1)Pdm09 and H3N2 Infection","volume":"176","author":"Martinez","year":"2023","journal-title":"Microb. Pathog."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"21259","DOI":"10.1038\/s41598-021-00809-2","article-title":"Co-Infection of SARS-CoV-2 and Influenza Virus Causes More Severe and Prolonged Pneumonia in Hamsters","volume":"11","author":"Kinoshita","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1093\/cid\/ciaa1747","article-title":"Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)Pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters","volume":"72","author":"Zhang","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-021-00618-z","article-title":"Sequential Infection with H1N1 and SARS-CoV-2 Aggravated COVID-19 Pathogenesis in a Mammalian Model, and Co-Vaccination as an Effective Method of Prevention of COVID-19 and Influenza","volume":"6","author":"Bao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3201\/eid2606.200299","article-title":"Co-Infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China","volume":"26","author":"Wu","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Dadashi, M., Khaleghnejad, S., Abedi Elkhichi, P., Goudarzi, M., Goudarzi, H., Taghavi, A., Vaezjalali, M., and Hajikhani, B. (2021). COVID-19 and Influenza Co-Infection: A Systematic Review and Meta-Analysis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.681469"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11596-021-2317-2","article-title":"Co-Infection of SARS-COV-2 and Influenza A Virus: A Case Series and Fast Review","volume":"41","author":"Xiang","year":"2021","journal-title":"Curr. Med. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.46234\/ccdcw2021.228","article-title":"Public Health Control Measures for the Co-Circulation of Influenza and SARS-CoV-2 During Influenza Seasons","volume":"4","author":"Tam","year":"2022","journal-title":"China CDC Wkly."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/ije\/dyab081","article-title":"Interactions between SARS-CoV-2 and Influenza, and the Impact of Coinfection on Disease Severity: A Test-Negative Design","volume":"50","author":"Stowe","year":"2021","journal-title":"Int. J. Epidemiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1016\/j.vaccine.2016.11.005","article-title":"Simultaneous Vaccination with MMR and DTaP-IPV-Hib and Rate of Hospital Admissions with Any Infections: A Nationwide Register Based Cohort Study","volume":"34","author":"Benn","year":"2016","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Sansone, V., Miraglia del Giudice, G., Della Polla, G., and Angelillo, I.F. (2024). Simultaneous Vaccination against Seasonal Influenza and COVID-19 among the Target Population in Italy. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1431963"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Dudley, M.Z., Salmon, D.A., Halsey, N.A., Orenstein, W.A., Limaye, R.J., O\u2019Leary, S.T., and Omer, S.B. (2018). Do Combination Vaccines or Simultaneous Vaccination Increase the Risk of Adverse Events?. The Clinician\u2019s Vaccine Safety Resource Guide, Springer International Publishing.","DOI":"10.1007\/978-3-319-94694-8_20"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e2443166","DOI":"10.1001\/jamanetworkopen.2024.43166","article-title":"Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial","volume":"7","author":"Walter","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2195786","DOI":"10.1080\/21645515.2023.2195786","article-title":"Vaccine Co-Administration in Adults: An Effective Way to Improve Vaccination Coverage","volume":"19","author":"Bonanni","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_64","unstructured":"(2026, March 14). Simultaneous Administration of COVID-19 Vaccines and Other Vaccines, Available online: https:\/\/www.cdc.gov\/covid\/hcp\/vaccine-considerations\/implementation.html."},{"key":"ref_65","unstructured":"(2026, February 12). Statement on the Antigen Composition of COVID-19 Vaccines. Available online: https:\/\/www.who.int\/news\/item\/15-05-2025-statement-on-the-antigen-composition-of-covid-19-vaccines."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0095-4543(05)70039-7","article-title":"Combination Vaccines","volume":"28","author":"Decker","year":"2001","journal-title":"Prim. Care Clin. Off. Pract."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0974-777X.77298","article-title":"Combination Vaccines","volume":"3","author":"Skibinski","year":"2011","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1080\/21645515.2015.1044180","article-title":"The Value of Childhood Combination Vaccines: From Beliefs to Evidence","volume":"11","author":"Maman","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2024.7370","article-title":"Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available","volume":"331","author":"Rubin","year":"2024","journal-title":"JAMA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/oxfordjournals.epirev.a017991","article-title":"Combination Vaccines: Issues in Evaluation of Effectiveness and Safety","volume":"21","author":"Guess","year":"1999","journal-title":"Epidemiol. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.326.7397.995","article-title":"Safety and Efficacy of Combination Vaccines: Combinations Reduce Distress and Are Efficacious and Safe","volume":"326","author":"Elliman","year":"2003","journal-title":"BMJ"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00006454-200111001-00007","article-title":"Safety of Combination Vaccines: Perception versus Reality","volume":"20","author":"Halsey","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14760584.2020.1843434","article-title":"Efficacy, Safety, and Formulation Issues of the Combined Vaccines","volume":"19","author":"Tafreshi","year":"2020","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"126043","DOI":"10.1016\/j.ijpharm.2025.126043","article-title":"An Intranasal Quadruple Variant Vaccine Approach Using SARS-CoV-2 and Influenza A: Delta, Omicron, H1N1and H3N2","volume":"683","author":"Singh","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e00689-22","DOI":"10.1128\/jvi.00689-22","article-title":"A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice","volume":"96","author":"Chaparian","year":"2022","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"eabo4100","DOI":"10.1126\/sciadv.abo4100","article-title":"A SARS-CoV-2 and Influenza Double Hit Vaccine Based on RBD-Conjugated Inactivated Influenza A Virus","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"126463","DOI":"10.1016\/j.vaccine.2024.126463","article-title":"SARS-CoV-2 Spike-Based Virus-like Particles Incorporate Influenza H1\/N1 Antigens and Induce Dual Immunity in Mice","volume":"42","author":"Stuible","year":"2024","journal-title":"Vaccine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"104297","DOI":"10.1016\/j.ebiom.2022.104297","article-title":"A Combination Vaccine against SARS-CoV-2 and H1N1 Influenza Based on Receptor Binding Domain Trimerized by Six-Helix Bundle Fusion Core","volume":"85","author":"Shi","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.vaccine.2023.12.084","article-title":"Flu-COVID Combo Recombinant Protein Vaccines Elicited Protective Immune Responses against Both Influenza and SARS-CoV-2 Viruses Infection","volume":"42","author":"Huang","year":"2024","journal-title":"Vaccine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2023.11.057","article-title":"Transformative Vaccination: A Pentavalent Shield against COVID-19 and Influenza with Betulin-Based Adjuvant for Enhanced Immunity","volume":"42","author":"Krasilnikov","year":"2024","journal-title":"Vaccine"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41541-022-00478-w","article-title":"Rational Development of a Combined mRNA Vaccine against COVID-19 and Influenza","volume":"7","author":"Ye","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e00668-24","DOI":"10.1128\/mbio.00668-24","article-title":"A Decavalent Composite mRNA Vaccine against Both Influenza and COVID-19","volume":"15","author":"Wang","year":"2024","journal-title":"mBio"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"126825","DOI":"10.1016\/j.vaccine.2025.126825","article-title":"Co-Administration of Seasonal Quadrivalent Influenza and COVID-19 Vaccines Leads to Enhanced Immune Responses to Influenza Virus and Reduced Immune Responses to SARS-CoV-2 in Naive Mice","volume":"50","author":"Abbad","year":"2025","journal-title":"Vaccine"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Thornhill-Wadolowski, E., Ruter, D.L., Yan, F., Gajera, M., Kurt, E., Samanta, L., Leigh, K., Zhu, J., Guo, Z., and Wang, Z. (2025). Development of an Influenza\/COVID-19 Combination mRNA Vaccine Containing a Novel Multivalent Antigen Design That Enhances Immunogenicity of Influenza Virus B Hemagglutinins. Vaccines, 13.","DOI":"10.3390\/vaccines13060628"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"102210","DOI":"10.1016\/j.coi.2022.102210","article-title":"Viral Vector Vaccines","volume":"77","author":"McCann","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Vasilyev, K., Shurygina, A.-P., Sergeeva, M., Stukova, M., and Egorov, A. (2021). Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs. Microorganisms, 9.","DOI":"10.3390\/microorganisms9040690"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e01578-21","DOI":"10.1128\/jvi.01578-21","article-title":"A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice","volume":"96","author":"Cao","year":"2022","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41541-024-00857-5","article-title":"An Intranasal Combination Vaccine Induces Systemic and Mucosal Immunity against COVID-19 and Influenza","volume":"9","author":"Xing","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/bioe.21950","article-title":"Engineering Influenza Viral Vectors","volume":"4","author":"Li","year":"2013","journal-title":"Bioengineered"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/viro.1998.9508","article-title":"Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems","volume":"252","author":"Egorov","year":"1998","journal-title":"Virology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1128\/JVI.72.8.6437-6441.1998","article-title":"Transfectant Influenza A Viruses with Long Deletions in the NS1 Protein Grow Efficiently in Vero Cells","volume":"72","author":"Egorov","year":"1998","journal-title":"J. Virol."},{"key":"ref_92","unstructured":"Vivaldi Biosciences (2026, March 10). Delta-19, COVID-19 + Universal Influenza Combination Vaccine. Available online: https:\/\/vivaldibiosciences.com\/delta19."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Sergeeva, M.V., Vasilev, K., Romanovskaya-Romanko, E., Yolshin, N., Pulkina, A., Shamakova, D., Shurygina, A.-P., Muzhikyan, A., Lioznov, D., and Stukova, M. (2024). Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Na\u00efve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice. Vaccines, 13.","DOI":"10.3390\/vaccines13010015"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A Live Attenuated Virus-Based Intranasal COVID-19 Vaccine Provides Rapid, Prolonged, and Broad Protection against SARS-CoV-2","volume":"67","author":"Chen","year":"2022","journal-title":"Sci. Bull."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/s41467-023-39560-9","article-title":"Intranasal Influenza-Vectored COVID-19 Vaccine Restrains the SARS-CoV-2 Inflammatory Response in Hamsters","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Loes, A.N., Gentles, L.E., Greaney, A.J., Crawford, K.H., and Bloom, J.D. (2020). Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice. Viruses, 12.","DOI":"10.1101\/2020.08.12.248823"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Stepanova, E., Matyushenko, V., Mezhenskaya, D., Bazhenova, E., Kotomina, T., Rak, A., Donina, S., Chistiakova, A., Kostromitina, A., and Novitskaya, V. (2024). Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters. Vaccines, 12.","DOI":"10.3390\/vaccines12121300"},{"key":"ref_98","unstructured":"(2026, March 06). Influenza and COVID-19: Vaccination Campaign Extended. Available online: https:\/\/www.service-public.gouv.fr\/particuliers\/actualites\/A17729?lang=en."},{"key":"ref_99","unstructured":"(2026, March 06). Summary of the NACI Seasonal Influenza Vaccine Statement for 2025\u20132026. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/reports-publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2025-51\/issue-9-september-2025\/summary-naci-seasonal-influenza-vaccine-statement-2025\u20132026.html."},{"key":"ref_100","unstructured":"(2026, March 14). Get Flu and COVID-19 Shots for Good Health: Publicly Funded Flu and COVID-19 Vaccination Program Launched on October 1, Available online: https:\/\/www.cdc.gov.tw\/En\/Bulletin\/Detail\/zRikIHnEeY1yZj_UP0vFpw?typeid=158#:~:text=Drawing%20on%20his%20previous%20experience,providing%20publicly%20funded%20vaccination%20services."},{"key":"ref_101","unstructured":"(2026, March 14). China CDC Issues Guidelines on Influenza Vaccination in China (2022\u20132023). Available online: https:\/\/en.chinacdc.cn\/health_topics\/infectious_diseases\/202208\/t20220829_261009.html."},{"key":"ref_102","unstructured":"(2026, March 10). Co-Administration of COVID-19 Vaccine and Seasonal Influenza Vaccine, Available online: https:\/\/www.chp.gov.hk\/en\/features\/106096.html."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e2222241","DOI":"10.1001\/jamanetworkopen.2022.22241","article-title":"Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US","volume":"5","author":"Hause","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S2213-2600(21)00557-9","article-title":"Safety and Immunogenicity of a High-Dose Quadrivalent Influenza Vaccine Administered Concomitantly with a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged \u226565 Years: A Phase 2, Randomised, Open-Label Study","volume":"10","author":"Izikson","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e2342151","DOI":"10.1001\/jamanetworkopen.2023.42151","article-title":"Estimated Effectiveness of Co-administration of the BNT162b2 BA.4\/5 COVID-19 Vaccine with Influenza Vaccine","volume":"6","author":"McGrath","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.vaccine.2022.12.069","article-title":"Safety of Co-Administration of mRNA COVID-19 and Seasonal Inactivated Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS) during July 1, 2021\u2013June 30, 2022","volume":"41","author":"Moro","year":"2023","journal-title":"Vaccine"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2213-2600(21)00409-4","article-title":"Safety, Immunogenicity, and Efficacy of a COVID-19 Vaccine (NVX-CoV2373) Co-Administered with Seasonal Influenza Vaccines: An Exploratory Substudy of a Randomised, Observer-Blinded, Placebo-Controlled, Phase 3 Trial","volume":"10","author":"Toback","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/S0140-6736(21)02329-1","article-title":"Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults in the UK (ComFluCOV): A Multicentre, Randomised, Controlled, Phase 4 Trial","volume":"398","author":"Lazarus","year":"2021","journal-title":"Lancet"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/idr14060098","article-title":"The Importance of COVID-19\/Influenza Vaccines Co-Administration: An Essential Public Health Tool","volume":"14","author":"Venuto","year":"2022","journal-title":"Infect. Dis. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2287282","DOI":"10.1080\/21645515.2023.2287282","article-title":"Co-Administration of SARS-CoV-2 and Influenza Vaccines in Healthcare Workers: Results of Two Vaccination Campaigns in a Large Teaching Hospital in Rome","volume":"19","author":"Pascucci","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2327229","DOI":"10.1080\/21645515.2024.2327229","article-title":"Real-Life Experience on COVID-19 and Seasonal Influenza Vaccines Co-Administration in the Vaccination Hub of the University Hospital of Palermo, Italy","volume":"20","author":"Costantino","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2201390","DOI":"10.1183\/13993003.01390-2022","article-title":"Immunogenicity and Safety of Co-administration of COVID-19 and Influenza Vaccination","volume":"61","author":"Reusch","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e2332813","DOI":"10.1001\/jamanetworkopen.2023.32813","article-title":"Immunogenicity and Reactogenicity of Co-administration of COVID-19 and Influenza Vaccines","volume":"6","author":"Gonen","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s40121-023-00863-5","article-title":"Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults","volume":"12","author":"Murdoch","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1016\/j.vaccine.2022.07.021","article-title":"Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine (CoronaVac) Co-Administered with an Inactivated Quadrivalent Influenza Vaccine: A Randomized, Open-Label, Controlled Study in Healthy Adults Aged 18 to 59 Years in China","volume":"40","author":"Wang","year":"2022","journal-title":"Vaccine"},{"key":"ref_116","unstructured":"ModernaTX Inc (2026, March 10). A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19\/Influenza) Vaccine in Adults 18 to 75 Years Old, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05375838."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e187075","DOI":"10.1172\/jci.insight.187075","article-title":"Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines","volume":"10","author":"Lee","year":"2025","journal-title":"JCI Insight"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(24)00589-9","article-title":"Safety and Immunogenicity of mRNA-1345 RSV Vaccine Coadministered with an Influenza or COVID-19 Vaccine in Adults Aged 50 Years or Older: An Observer-Blinded, Placebo-Controlled, Randomised, Phase 3 Trial","volume":"25","author":"Goswami","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Acuti Martellucci, C., Rosso, A., Zauli, E., Bianconi, A., Fiore, M., Soldato, G., Marani Toro, P., De Benedictis, M., Di Marco, G., and Carota, R. (2025). The Effectiveness of Four Quadrivalent, Inactivated Influenza Vaccines Administered Alone or in Combination with Pneumococcal and\/or SARS-CoV-2 Vaccines: A Population-Wide Cohort Study. Vaccines, 13.","DOI":"10.3390\/vaccines13030309"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"103428","DOI":"10.1016\/j.eclinm.2025.103428","article-title":"Immunogenicity and Safety of Self-Amplifying mRNA COVID-19 Vaccine (ARCT-2303), with or without Co-Administration of Seasonal Inactivated Influenza Vaccine in Adults: A Phase 3, Randomised, Controlled, Observer-Blind, Multicentre Study","volume":"87","author":"Giles","year":"2025","journal-title":"eClinicalMedicine"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"103016","DOI":"10.1016\/j.eclinm.2024.103016","article-title":"Safety, Reactogenicity, and Immunogenicity of Ad26. COV2. S Co-Administered with a Quadrivalent Standard-Dose or High-Dose Seasonal Influenza Vaccine: A Non-Inferiority Randomised Controlled Trial","volume":"79","author":"Aguilar","year":"2025","journal-title":"eClinicalMedicine"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"128072","DOI":"10.1016\/j.vaccine.2025.128072","article-title":"Immunogenicity of mRNA COVID-19 Vaccine with Either Simultaneous or Sequentially Administered Inactivated Influenza Vaccines: A Randomized Clinical Trial","volume":"72","author":"Walter","year":"2026","journal-title":"Vaccine"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Boikos, C., Schaible, K., Nunez-Gonzalez, S., Welch, V., Hu, T., Kyaw, M.H., Choi, L.E., Kamar, J., Goebe, H., and McLaughlin, J. (2025). Co-Administration of BNT162b2 COVID-19 and Influenza Vaccines in Adults: A Global Systematic Review. Vaccines, 13.","DOI":"10.3390\/vaccines13040381"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2131166","DOI":"10.1080\/21645515.2022.2131166","article-title":"Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies","volume":"18","author":"Janssen","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e2314757","DOI":"10.1001\/jamanetworkopen.2023.14757","article-title":"Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel","volume":"6","author":"Gilboa","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cmi.2022.12.008","article-title":"Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: Results of a prospective cohort study in 838 health workers","volume":"29","author":"Radner","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"128194","DOI":"10.1016\/j.vaccine.2026.128194","article-title":"Spike antibody levels and risk of SARS-CoV-2 reinfection: A two-year cohort study in previously infected adults","volume":"74","author":"Wiwe","year":"2026","journal-title":"Vaccine"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Al Hashimi, F., Shuaib, S.E., Bragazzi, N.L., Chen, S., and Wu, J. (2025). COVID-19 Vaccine Timing and Co-Administration with Influenza Vaccines in Canada: A Systematic Review with Comparative Insights from G7 Countries. Vaccines, 13.","DOI":"10.3390\/vaccines13070670"},{"key":"ref_129","unstructured":"Pfizer, and BioNTech (2026, March 02). Pfizer and BioNTech Provide Update on mRNA-Based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18\u201364 Years of Age [Press Release]. Available online: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-provide-update-mrna-based-combination."},{"key":"ref_130","first-page":"2589644","article-title":"Phase 1\/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adults","volume":"1","author":"Henry","year":"2026","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41591-025-03591-0","article-title":"mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine in healthy adults: A phase 1\/2 trial","volume":"31","author":"Ananworanich","year":"2025","journal-title":"Nat. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.2025.5646","article-title":"Immunogenicity and safety of influenza and COVID-19 multicomponent vaccine in adults \u2265 50 years: A randomized clinical trial","volume":"333","author":"Wu","year":"2025","journal-title":"JAMA"},{"key":"ref_133","unstructured":"GlaxoSmithKline (2026, March 06). A Study of an Investigational Flu Seasonal\/SARS-CoV-2 Combination Vaccine in Adults, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06680375."},{"key":"ref_134","unstructured":"(2026, March 02). A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine (COVID-19), Available online: https:\/\/clinicaltrials.gov\/study\/NCT05519839."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S2213-2600(22)00131-X","article-title":"Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARSCoV-2 vaccine in adults: Randomised, double-blind, placebo-controlled, phase 1 and 2 trials","volume":"10","author":"Zhu","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S2213-2600(23)00349-1","article-title":"Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"11","author":"Zhu","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_137","unstructured":"(2026, March 06). Smorodintsev Research Institute of Influenza, Russia Evalution of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05696067."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Neutel, J.M., Erdem, R., Jiang, Q., Cannon, K., Stacey, H., Newton, R., Gomme, E., Li, W., Mensa, F.J., and Tureci, O. (2025). Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults >\/= 65 Years of Age. Vaccines, 13.","DOI":"10.3390\/vaccines13020158"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Wei, Z., and Yu, S. (2025). Real-world feasibility of co-administration of RSV, COVID-19, and influenza vaccines in older adults: A VAERS-based analysis. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1682119"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/3\/283\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:04:55Z","timestamp":1774260295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/3\/283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":139,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["vaccines14030283"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14030283","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}